Abstract:The purpose of this article is to update the changes to the author's protocols used to manage acute filler related vascular events from those previously published in this journal. For lack of a better term, this new protocol has been called the High Dose Pulsed Hyaluronidase (HDPH) protocol for vascular embolic events with hyaluronic acid (HA) fillers. The initial protocol used involved many different modalities of treatment. The current protocol is exceedingly simple and involves solely the use of hyaluronidase in repeated high doses. Despite the simplicity of the treatment, it has proven itself to be very successful over the past two years of clinical use. There has been no partial or complete skin loss associated with this protocol since its implementation if the protocol was implemented within 2 days of the ischemic event onset. The protocol involves diagnosis and repeated administration of relatively high doses hyaluronidase (HYAL) into the ischemic tissue repeated hourly until resolution (as detected clinically through capillary refill, skin color, and absence of pain). The dosage of HYAL varies as the amount of ischemic tissue, consistent with the new underlying hypothesis that we must flood the occluded vessels with a sufficient concentration of HYAL for a sufficient period of time in order to dissolve the HA obstruction to the point where the products of hydrolysis can pass through the capillary beds. Although vascular embolic events are rare, it is important to note that the face has higher risk and lower risk areas for filler treatment, but there are no "zero risk" areas with respect to filler treatments. Even with good anatomic knowledge and correct technique, there is still some nonzero risk of vascular embolic events (including highly skilled, experienced injectors). However, with careful low pressure, low volume injection technique, and adequate preparation for treatment of acute vascular events, the risk is quite manageable and the vast majority of adverse events are very treatable with an excellent prognosis, with a few exceptions. This new protocol offers excellent results, but requires further research to determine optimal parameters for various HA fillers.

Reversal of Post-filler Vision Loss and Skin Ischaemia with High-Dose Pulsed Hyaluronidase Injections

Acute unilateral vision loss and bilateral cerebral infarction following cosmetic filler injection

Retinal Branch Artery Embolization Following Hyaluronic Acid Injection: A Case Report.

Acute diplopia after glabellar hyaluronic acid filler injection

Monocular Vision Loss After Ear Filler Injection

Administration Method and Potential Efficacy of Hyaluronidase for Hyaluronic Acid Filler-Related Vision Loss: A Systematic Review.

A Case of Visual Loss Following Injection of Poly-(L)-Lactic Acid Filler into the Right Forehead

Resolution of Vascular Compromise From Liquid Rhinoplasty Using Hirudo medicinalis Therapy

Isolated Ophthalmoplegia After Periorbital Hyaluronic Acid Filler Injection

Panophthalmoplegia and Vision Loss after Cosmetic Nasal Dorsum Injection

Retinal artery occlusion after facial filler injection in a patient with patent foramen ovale: a case report and literature review

Ocular Complications Following Autologous Fat Injections into Facial Area: Case Report of a Recovery from Visual Loss After Ophthalmic Artery Occlusion and a Review of the Literature

Delayed Diagnosis of Septal Ulcer after Hyaluronic Acid Nasal Filler Injection

New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events

Treacherous territory: Temple fillers and tissue necrosis

Update on Blindness From Filler: Review of Prognostic Factors, Management Approaches, and a Century of Published Cases

Periorbital Lumps After the Injection of Hyaluronic Acid of Forehead: A Complication of Facial Fillers

Causes and management of sight threatening complications of dermal filler injections: A review

A treatment algorithm for hyaluronic acid filler related complications of the face

Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous Dinoprostone

Trigeminal Neuralgia after Hyaluronic Acid and Botox Injection